NeOnc Technologies Holdings, Inc. (NTHI) Stock

Healthcare · Biotechnology · Member of Other US Stocks

NeOnc Technologies Holdings, Inc. (NTHI) closed at USD 2.66 on 2026-10-14, a change of -69.8 % over the past year, with a market capitalization of USD 79.21M.

NeOnc Technologies Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

NeOnc Technologies Holdings, Inc. key figures

Previous close

USD 2.66 (2026-10-14)

1-year change

-69.8 %

Market cap

USD 79.21M

Enterprise value

USD 69.85M

P/E ratio (trailing)

-1.23

P/E ratio (forward)

-2.52

EPS (trailing)

-2.24

EPS (forward)

-1.09

PEG ratio

n/a

Price to book

-3.15

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.77

Employees

5

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for NeOnc Technologies Holdings, Inc. and compare it with other stocks.